MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM)
Organization & Developments: Reneo
Parents
Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM)
Children
2022: Reneo Pharmaceuticals (RPHM) Investor Presentation - Slideshow_seekingalpha.com
2023: Reneo Pharmaceuticals: Buy Before Upcoming Pivotal Data Drop (NASDAQ:RPHM)
2023: Reneo Pharmaceuticals: Interesting, Undercovered Company Developing Mitochondrial Disease Therapies_ seekingalpha.com
It focuses on the development of treatments for genetic disorders associated with defects in energy metabolism resulting in myopathy that enable caregivers to improve the daily function and quality of life of patients suffering from these diseases by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness, and wasting.
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.
Jumps
Finance & Acquisitions: Reneo
Key People: Reneo